Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.
Multiple plasma proteins are elevated in presymptomatic and symptomatic ADAD mutation carriers relative to non-carriers, and combining biomarkers may help in staging presymptomatic AD and optimise clinical trial inclusion.